Delcath Systems (DCTH) had the highest return between December 31, 2017 and February 20, 2018 by a small-cap US stock, returning 26,320.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Delcath Systems (DCTH) | 12/31/2017 - 2/20/2018 | 26,320.23% |
POET Technologies (POET) | 12/31/2017 - 2/20/2018 | 170.59% |
Eastman Kodak (KODK) | 12/31/2017 - 2/20/2018 | 118.03% |
Gyre Therapeutics (GYRE) | 12/31/2017 - 2/20/2018 | 116.28% |
Fubotv (FUBO) | 12/31/2017 - 2/20/2018 | 114.29% |
Iovance Biotherapeutics (IOVA) | 12/31/2017 - 2/20/2018 | 111.73% |
InnovAge (INNV) | 12/31/2017 - 2/20/2018 | 104.82% |
Novavax (NVAX) | 12/31/2017 - 2/20/2018 | 96.75% |
BlueLinx (BXC) | 12/31/2017 - 2/20/2018 | 74.21% |
Newegg Commerce (NEGG) | 12/31/2017 - 2/20/2018 | 72.16% |
eXp World (EXPI) | 12/31/2017 - 2/20/2018 | 66.88% |
Larimar Therapeutics (LRMR) | 12/31/2017 - 2/20/2018 | 66.74% |
Know Labs (KNW) | 12/31/2017 - 2/20/2018 | 56.81% |
Rocket Pharmaceuticals (RCKT) | 12/31/2017 - 2/20/2018 | 55.74% |
QuinStreet (QNST) | 12/31/2017 - 2/20/2018 | 51.67% |
Liquidity Services (LQDT) | 12/31/2017 - 2/20/2018 | 50% |
Wave Life Sciences (WVE) | 12/31/2017 - 2/20/2018 | 48.43% |
Kura Oncology (KURA) | 12/31/2017 - 2/20/2018 | 43.23% |
Enanta Pharmaceuticals (ENTA) | 12/31/2017 - 2/20/2018 | 41.33% |
Zevra Therapeutics (ZVRA) | 12/31/2017 - 2/20/2018 | 40.74% |
Nektar Therapeutics (NKTR) | 12/31/2017 - 2/20/2018 | 40.09% |
Collegium Pharmaceutical (COLL) | 12/31/2017 - 2/20/2018 | 38.84% |
eGain (EGAN) | 12/31/2017 - 2/20/2018 | 38.32% |
ANGI Homeservices (ANGI) | 12/31/2017 - 2/20/2018 | 37.74% |
Community Health Systems (CYH) | 12/31/2017 - 2/20/2018 | 37.15% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
